Chronic cough, defined as a cough persisting over eight weeks, is a challenging condition to diagnose and manage. It not only impacts the patient's quality of life but also poses a diagnostic dilemma for clinicians due to its multifactorial etiology.
A systematic and comprehensive approach is paramount for the successful diagnosis of chronic cough. The initial evaluation should include a detailed history and physical examination to identify common causes such as upper airway cough syndrome, gastroesophageal reflux disease (GERD), and asthma. If the cough persists despite initial therapy, further investigations such as chest radiographs, spirometry, and bronchoprovocation tests may be warranted.
Imaging studies, particularly high-resolution computed tomography (HRCT), can reveal underlying pulmonary disorders. Laboratory tests, including complete blood count (CBC), can help identify eosinophilic bronchitis. In refractory cases, bronchoscopy may be necessary to evaluate for conditions like endobronchial tumors or foreign bodies.
Management of chronic cough should be tailored to the underlying cause. Empiric treatment for the most common causes such as GERD, asthma, and postnasal drip syndrome can be initiated. In refractory cases, a multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be required.
Recent advancements in the understanding of chronic cough pathophysiology have led to the development of promising therapies. Neuromodulators such as gabapentin and pregabalin have shown efficacy in refractory chronic cough. Moreover, novel therapies targeting neuronal pathways, such as P2X3 receptor antagonists, are currently under investigation.
In conclusion, chronic cough remains a complex clinical entity requiring a comprehensive and systematic approach for effective diagnosis and management. Embracing a multidisciplinary approach, utilizing advanced diagnostic tools, and keeping abreast of emerging therapies can significantly improve patient outcomes.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation